187 related articles for article (PubMed ID: 29212525)
1. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
Yu J; Qin B; Moyer AM; Sinnwell JP; Thompson KJ; Copland JA; Marlow LA; Miller JL; Yin P; Gao B; Minter-Dykhouse K; Tang X; McLaughlin SA; Moreno-Aspitia A; Schweitzer A; Lu Y; Hubbard J; Northfelt DW; Gray RJ; Hunt K; Conners AL; Suman VJ; Kalari KR; Ingle JN; Lou Z; Visscher DW; Weinshilboum R; Boughey JC; Goetz MP; Wang L
Breast Cancer Res; 2017 Dec; 19(1):130. PubMed ID: 29212525
[TBL] [Abstract][Full Text] [Related]
2. Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
Goetz MP; Kalari KR; Suman VJ; Moyer AM; Yu J; Visscher DW; Dockter TJ; Vedell PT; Sinnwell JP; Tang X; Thompson KJ; McLaughlin SA; Moreno-Aspitia A; Copland JA; Northfelt DW; Gray RJ; Hunt K; Conners A; Sicotte H; Eckel-Passow JE; Kocher JP; Ingle JN; Ellingson MS; McDonough M; Wieben ED; Weinshilboum R; Wang L; Boughey JC
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376176
[TBL] [Abstract][Full Text] [Related]
3. Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.
Kanaya N; Somlo G; Wu J; Frankel P; Kai M; Liu X; Wu SV; Nguyen D; Chan N; Hsieh MY; Kirschenbaum M; Kruper L; Vito C; Badie B; Yim JH; Yuan Y; Hurria A; Peiguo C; Mortimer J; Chen S
J Steroid Biochem Mol Biol; 2017 Jun; 170():65-74. PubMed ID: 27154416
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with engraftment success of patient-derived xenografts of breast cancer.
Lee J; Lee G; Park HS; Jeong BK; Gong G; Jeong JH; Lee HJ
Breast Cancer Res; 2024 Mar; 26(1):49. PubMed ID: 38515107
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity.
Chen X; Shen C; Wei Z; Zhang R; Wang Y; Jiang L; Chen K; Qiu S; Zhang Y; Zhang T; Chen B; Xu Y; Feng Q; Huang J; Zhong Z; Li H; Che G; Xiao K
Cancer Biol Med; 2021 Feb; 18(1):184-198. PubMed ID: 33628593
[TBL] [Abstract][Full Text] [Related]
6. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
Philp LK
Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
Dobrolecki LE; Airhart SD; Alferez DG; Aparicio S; Behbod F; Bentires-Alj M; Brisken C; Bult CJ; Cai S; Clarke RB; Dowst H; Ellis MJ; Gonzalez-Suarez E; Iggo RD; Kabos P; Li S; Lindeman GJ; Marangoni E; McCoy A; Meric-Bernstam F; Piwnica-Worms H; Poupon MF; Reis-Filho J; Sartorius CA; Scabia V; Sflomos G; Tu Y; Vaillant F; Visvader JE; Welm A; Wicha MS; Lewis MT
Cancer Metastasis Rev; 2016 Dec; 35(4):547-573. PubMed ID: 28025748
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the treatment strategies on patient-derived xenograft mice of human breast tumor.
Khalighfard S; Alizadeh AM; Poorkhani A; Motahari M; Tahmasebifar A; Omranipour R; Keshavarz P; Haddad P
Eur J Pharmacol; 2020 Dec; 889():173605. PubMed ID: 32980347
[TBL] [Abstract][Full Text] [Related]
9. The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer.
Lewis MT; Caldas C
Cold Spring Harb Perspect Med; 2024 Apr; 14(4):. PubMed ID: 38052483
[TBL] [Abstract][Full Text] [Related]
10. Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer.
Sengal AT; Pollock PM
Methods Mol Biol; 2024; 2806():101-115. PubMed ID: 38676799
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases.
Baschnagel AM; Kaushik S; Durmaz A; Goldstein S; Ong IM; Abel L; Clark PA; Gurel Z; Leal T; Buehler D; Iyer G; Scott JG; Kimple RJ
Sci Rep; 2021 Jan; 11(1):2520. PubMed ID: 33510214
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer.
Galli G; Bregni G; Cavalieri S; Porcu L; Baili P; Hade A; Di Salvo F; Sant M; Agresti R; Gennaro M; Folli S; De Santis MC; Paolini B; Carcangiu ML; de Braud F; Di Cosimo S
Breast Care (Basel); 2017 Dec; 12(6):391-394. PubMed ID: 29456471
[TBL] [Abstract][Full Text] [Related]
13. Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.
He F; Bandyopadhyay AM; Klesse LJ; Rogojina A; Chun SH; Butler E; Hartshorne T; Holland T; Garcia D; Weldon K; Prado LP; Langevin AM; Grimes AC; Sugalski A; Shah S; Assanasen C; Lai Z; Zou Y; Kurmashev D; Xu L; Xie Y; Chen Y; Wang X; Tomlinson GE; Skapek SX; Houghton PJ; Kurmasheva RT; Zheng S
Nat Commun; 2023 Nov; 14(1):7600. PubMed ID: 37990009
[TBL] [Abstract][Full Text] [Related]
14. A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors.
Rajaram S; Roth MA; Malato J; VandenBerg S; Hann B; Atreya CE; Altschuler SJ; Wu LF
Sci Data; 2019 Oct; 6(1):253. PubMed ID: 31672976
[TBL] [Abstract][Full Text] [Related]
15. Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.
Anselmino N; Labanca E; Shepherd PDA; Dong J; Yang J; Song X; Nandakumar S; Kundra R; Lee C; Schultz N; Zhang J; Araujo JC; Aparicio AM; Subudhi SK; Corn PG; Pisters LL; Ward JF; Davis JW; Vazquez ES; Gueron G; Logothetis CJ; Futreal A; Troncoso P; Chen Y; Navone NM
Clin Cancer Res; 2024 May; 30(10):2272-2285. PubMed ID: 38488813
[TBL] [Abstract][Full Text] [Related]
16. Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience.
Nishie R; Tanaka T; Hirosuna K; Miyamoto S; Murakami H; Tsuchihashi H; Toji A; Ueda S; Morita N; Hashida S; Daimon A; Terada S; Maruoka H; Konishi H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731247
[No Abstract] [Full Text] [Related]
17. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment.
Cui Y; Ran R; Da Y; Zhang H; Jiang M; Qi X; Zhang W; Niu L; Zhou Y; Zhou C; Tang X; Wang K; Yan Y; Ren Y; Dong D; Zhou Y; Wang H; Gong J; Hu F; Zhao S; Zhang H; Zhang C; Yang J
J Cell Mol Med; 2024 May; 28(9):e18374. PubMed ID: 38722288
[TBL] [Abstract][Full Text] [Related]
18. Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor.
Wen S; Lin X; Luo W; Pan Y; Liao F; Wang Z; Zhan B; Feng J; Huang H
BMC Cancer; 2024 Apr; 24(1):485. PubMed ID: 38632504
[TBL] [Abstract][Full Text] [Related]
19. The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers.
Thorel L; Divoux J; Lequesne J; Babin G; Morice PM; Florent R; Desmartin G; Lecouflet L; Marde Alagama C; Leconte A; Clarisse B; Briand M; Rouzier R; Gaichies L; Martin-Françoise S; Le Brun JF; Denoyelle C; Vigneron N; Jeanne C; Blanc-Fournier C; Leman R; Vaur D; Figeac M; Meryet-Figuiere M; Joly F; Weiswald LB; Poulain L; Dolivet E
BMC Cancer; 2024 Jun; 24(1):701. PubMed ID: 38849726
[TBL] [Abstract][Full Text] [Related]
20. Characterization of BCL-X L , MCL-1, and BAX Protein Expression in Response to Neoadjuvant Chemotherapy in Breast Cancer.
Saleh T; Al Shboul S; Awad H; El-Sadoni M; Alhesa A; Alsharaiah E; Abu Shahin N; Alotaibi MR; Battah A; Azab B
Appl Immunohistochem Mol Morphol; 2024 Apr; 32(4):189-199. PubMed ID: 38426376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
